Dec 20,2022

Bill could pave the way for prescription digital therapeutics reimbursement

New legislation would allow for reimbursement of prescribed digital therapeutics under Medicare, which proponents argue could increase access to these emerging treatments. Still, others say it's new technology, and the wrong reimbursement model could tamper innovation and increase patient costs. The Access to Prescription Digital Therapeutics Act of 2022, introduced in the U.S. Senate in March, aims to amend the Social Security Act to provide Medicare coverage and reimbursement for prescription digital therapeutics.

#reimbursement

#software

#pdt

View Analyst & Ambassador Comments
Go to original news
Dec 27,2022

The Challenges, Potential, and Future of Digital Therapeutics in Healthcare

Earlier this year, CMS implemented a new Level II Healthcare Common Procedure Coding System (HCPCS) code for “prescription digital behavioral therapy,” which makes it easier for commercial and Medicaid plans to cover these therapies. Additionally, Congress is considering legislation called the Access to Prescription Digital Therapeutics Act, a bipartisan bill that would establish benefit categories for certain digital therapeutics so that they could be reimbursed by Medicare, Medicaid, and other public payers – a key roadblock that is currently blocking the way towards further adoption.

#reimbursement

#pdt

View Analyst & Ambassador Comments
Go to original news
Jul 01,2020

Former Rep. Patrick Kennedy, Pear, Shatterproof join forces on new addiction focused DTx coalition

Over the last decade, the addiction and mental health space has becoming increasingly digital – so much so that the first prescription digital therapeutic, Pear’s ReSET, scored FDA clearance nearly three years ago. While more and more players begin to join the so-called "DTx" space, the technology is yet to hit the mainstream radar, but a new coalition is looking to change that. A list of high-profile players in the addiction and recovery space, including Former Congressman Patrick Kennedy, D-R.I., 1995-2010, Pear Therapeutic, Shatterproof, and others in the space have come together to form the Recovery Access Coalition, which aims to advocate for access to prescription digital therapeutics.

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Aug 28,2020

Nicotine Addiction Treatment App With CO Checker Receives Regulatory Approval - CureApp, Inc.

CureApp, Inc. received regulatory authorization for the manufacturing and sale of Asia’s first therapeutics app, the “CureApp SC Nicotine Addiction Treatment App and CO Checker”, from the Ministry of Health, Labour and Welfare on August 21st, 2020. The Company is currently proceeding with plans to receive insurance reimbursement and release CureApp SC in FY2020.

PRODUCT

#reimbursement

#mobile app

View Analyst & Ambassador Comments
Go to original news
Sep 10,2020

With many regulatory barriers clear, remaining roadblocks for digital therapeutics are cultural, logistical

While some of the more obvious barriers to digital therapeutics adoption in Europe have come crashing down recently, adoption is still hampered by cultural momentum. That was the conclusion of a group of digital therapeutics stakeholders who presented at HIMSS & Health 2.0 Europe Digital Event today, in a session moderated by YourCoach Health chairman and COO Eugene Borukhovich.

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Nov 19,2020

Pear Therapeutics and Health Transformation Alliance Join in Providing Access for reSET® and reSET-O® to Self-insured Employers

Pear Therapeutics, Inc. and Health Transformation Alliance (HTA) announced today that reSET® and reSET-O®, the first two prescription digital therapeutics (PDTs) to receive authorization to treat disease from the U.S. Food and Drug Administration (FDA), have been added to HTA’s custom formulary as a standard pharmacy benefit. HTA will offer its 56 Member organizations the opportunity to add reSET and reSET-O to their formularies.

COLLABORATION PARTNERSHIP

#institution

#reimbursement

#pdt

View Analyst & Ambassador Comments
Go to original news
Dec 01,2020

CureApp SC, Digital Therapeutic for Nicotine Addiction: Introducing a New Form of App-based Prescription Treatment Reimbursed in Japan’s Public Healthcare Insurance System

CureApp, Inc has announced that CureApp SC Nicotine Addiction Treatment App and CO Checker – a treatment app(digital therapeutic) targeting nicotine addiction – is now covered by Japan’s public healthcare insurance system as of December 1, 2020, following a period of clinical trials and regulatory approval. This marks the first case of a digital therapeutics application being covered by the insurance, as well as the first time that a digital therapeutic in the field of smoking cessation treatments has been covered by a country’s national health insurance system in the world.

PRODUCT

#mobile app

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Dec 14,2020

Investors share five digital health predictions for 2021

After a banner year for digital health, characterized by record adoption and investment, what will come next? Partners with Boston Consulting Group’s Digital Ventures shared their predictions for 2021. A longtime goal for many digital health companies, next year a digital therapeutic might secure a major reimbursement deal with an insurer, predicts managing director and partner Nate Beyor.

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Dec 12,2019

Omada Health Selected for Express Scripts Industry-First Digital Health Formulary

Omada Health today announced that its digital care programs for Diabetes Prevention, Type 2 Diabetes, and Hypertension will be included on the Express Scripts Digital Health Formulary beginning in early 2020. Omada’s programs will be available to Express Scripts clients – including employers and group health plans – that implement the formulary as part of their pharmacy benefit.

COLLABORATION PARTNERSHIP

#institution

#reimbursement

#mobile app

View Analyst & Ambassador Comments
Go to original news
Dec 12,2019

SilverCloud Health Selected for Express Scripts Industry-First Digital Health Formulary for Mental and Behavioral Health

SilverCloud Health, one of the leading digital mental health platforms, today announced that Express Scripts, the largest independent manager of pharmacy benefits in the United States, will include SilverCloud’s evidenced-based digital mental health platform on its new digital health formulary in 2020. This makes the platform more widely available to people nationwide who are suffering from anxiety, depression, stress and sleep-related issues, like insomnia. Express Script’s digital health formulary will include digital and mobile health apps and devices to complement existing treatments.

COLLABORATION PARTNERSHIP

#institution

#reimbursement

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to REIMBURSEMENT